Ann is a General Partner at Engine Ventures. She serves as a Board Member for Cellino, Kano Therapeutics, Kytopen, Lucy Therapeutics, Matrisome Bio, Quaise, Syzygy Plasmonics, and Vaxess Technologies.
Ann was most recently at Sanofi where she held senior roles in business development and strategic venture investment. Prior to Sanofi, she was at Flagship Pioneering. Ann started her career in R&D at 3M Company, working across fields of materials, biology and engineering. Ann holds an MBA from Harvard and a PhD in Chemical Engineering from MIT. She served on the Board of Women in the Enterprise of Science and Technology and is on the Life Science Council of Springboard Enterprises. She serves as a Key Advisory Board member of Harvard’s Blavatnik Fellowship in Life Science Entrepreneurship, she is a member of Investment Advisory Committee for Prime Coalition and she serves on the Board of Directors of Nucleate.